In addition, the overexpression of BCL2, a key player in the apoptosis pathway, in NPC cells has been established since the 90s and has been implicated in NPC’s early stages due to its abnormal expression inhibiting apoptotic activities [49, 50]. The gene discussed is BCL2; the disease is nasopharyngeal carcinoma.